UB Paderborn / Katalog / Suche / in CDI

Abstract GS5-03: Lifestyle Intervention and Effect on Disease-free Survival in Early Breast Cancer Pts: Interim Analysis from the Randomized SUCCESS C Study

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.GS5-03-GS5-03

2019

Volltextzugriff (PDF)

Persistenz zirkulierender Tumorzellen direkt nach und zwei Jahre nach adjuvanter Chemotherapie bei Patientinnen mit früher Brustkrebserkrankung – Ergebnisse der SUCCESS Studien

Geburtshilfe und Frauenheilkunde, 2016, Vol.76 (10)

2016

Volltextzugriff (PDF)

Abstract OT1-1-11: DETECT III - A multicenter, randomized, phase III trial to compare standard therapy alone versus standard therapy plus lapatinib in patients with initially HER2-negative metastatic breast cancer and HER2-positive circulating tumor cells

Cancer research (Chicago, Ill.), 2013-12, Vol.73 (24_Supplement), p.OT1-1-11-OT1-1-11

2013

Volltextzugriff (PDF)

Abstract OT2-6-10: DETECT IV – A multicenter, single arm, phase II study evaluating the efficacy of everolimus in combination with endocrine therapy in patients with HER2-negative, hormone-receptor positive metastatic breast cancer and HER2-negative circulating tumor cells (CTCs)

Cancer research (Chicago, Ill.), 2013-12, Vol.73 (24_Supplement), p.OT2-6-10-OT2-6-10

2013

Volltextzugriff (PDF)

Abstract P4-13-11: Prognostic factors in young breast cancer patients over time – a 40 year longitudinal analysis

Cancer research (Chicago, Ill.), 2012-12, Vol.72 (24_Supplement), p.P4-P4-13-11

2012

Volltextzugriff (PDF)

Abstract PD6-6: A pooled analysis of the prognostic relevance of circulating tumor cells in early breast cancer

Cancer research (Chicago, Ill.), 2013-12, Vol.73 (24_Supplement), p.PD6-6-PD6-6

2013

Volltextzugriff (PDF)

Abstract OT1-1-10: DETECT III - A multicenter, randomized, phase III study to compare standard therapy alone versus standard therapy plus lapatinib in patients with initially HER2-negative metastatic breast cancer but with HER2-positive circulating tumorcells

Cancer research (Chicago, Ill.), 2012-12, Vol.72 (24_Supplement), p.OT1-1-10-OT1-1-10

2012

Volltextzugriff (PDF)

Abstract P1-10-11: Outcome of Patients with Early Breast Cancer Is Not Related to Their State of Social or Health Insurance

Cancer research (Chicago, Ill.), 2010-12, Vol.70 (24_Supplement), p.P1-P1-10-11

2010

Volltextzugriff (PDF)

Abstract P3-12-09: The prevalence and quantity of circulating tumor cells (CTCs) after adjuvant chemotherapy with and without anthracyclines in patients with HER2-negative early breast cancer (EBC)

Cancer research (Chicago, Ill.), 2013-12, Vol.73 (24_Supplement), p.P3-P3-12-09

2013

Volltextzugriff (PDF)

P5-14-05: Anti-Müllerian Hormone (AMH) Levels in Premenopausal Breast Cancer Patients Treated with Adjuvant Chemotherapy – A Translational Research Project of the SUCCESS Study

Cancer research (Chicago, Ill.), 2011-12, Vol.71 (24_Supplement), p.P5-P5-14-05

2011

Volltextzugriff (PDF)

Abstract PD04-08: Circulating tumor cells (CTC) in peripheral blood of breast cancer patients two years after adjuvant chemotherapy depending on endocrine treatment — The German SUCCESS-Trial

Cancer research (Chicago, Ill.), 2010-12, Vol.70 (24_Supplement), p.PD04-08-PD04-08

2010

Volltextzugriff (PDF)

Abstract P2-01-02: Circulating Tumor Cells (CTC) may Express HER2/neu in Patients With Early HER2/neu Negative Breast Cancer – Results of the German SUCCESS C Trial

Cancer research (Chicago, Ill.), 2012-12, Vol.72 (24_Supplement), p.P2-P2-01-02

2012

Volltextzugriff (PDF)

Abstract P3-10-20: The Prognostic Relevance of Serum CA27.29 level in Primary Breast Cancer Patients before Adjuvant Chemotherapy — Results of the German SUCCESS Trial

Cancer research (Chicago, Ill.), 2010-12, Vol.70 (24_Supplement), p.P3-P3-10-20

2010

Volltextzugriff (PDF)

CA 27.29 as a tumour marker for risk evaluation and therapy monitoring in patients with primary breast cancer

Cancer research (Chicago, Ill.), 2009-01, Vol.69 (2_Supplement), p.2004

2009

Volltextzugriff (PDF)

Treatment with trastuzumab in recurrence free patients with early breast cancer and persistent disseminated tumor cells (DTC) in bone marrow

Cancer research (Chicago, Ill.), 2009-01, Vol.69 (2_Supplement), p.3135

2009

Volltextzugriff (PDF)

Toxicity analysis of a phase III study evaluating FEC-Doc vs. FEC-Doc in combination with gemcitabine as adjuvant treatment for breast cancer – the SUCCESS-trial

Cancer research (Chicago, Ill.), 2009-01, Vol.69 (2_Supplement), p.4108

2009

Volltextzugriff (PDF)

Nachweis von Vascular Endothelial Growth Factor Receptor (VEGF-R) beim Mammakarzinom – Korrelation mit tumorbiologischen Faktoren und Disseminierten Tumorzellen im Knochenmark (DTZ-KM)

Geburtshilfe und Frauenheilkunde, 2006

2006

Volltextzugriff (PDF)

Benefit from participation in clinical trials

Geburtshilfe und Frauenheilkunde, 2006-09, Vol.66 (S 01)

2006

Volltextzugriff (PDF)

Die SUCCESS-Studie–ein innovatives Konzept zur Optimierung der adjuvanten Therapie beim frühen Mammakarzinom

Geburtshilfe und Frauenheilkunde, 2006, Vol.66 (S 01)

2006

Volltextzugriff (PDF)

Inzidenz zirkulierender Tumorzellen im peripheren Blut (CTC) bei Mammakarzinompatientinnen zum Zeitpunkt der Primärdiagnose – Ein potentieller Marker zur Risikostratifizierung

Geburtshilfe und Frauenheilkunde, 2006

2006

Volltextzugriff (PDF)

Nachweis von Vascular Endothelial Growth Factor Receptor (VEGF-R) beim Mammakarzinom – Korrelation mit tumorbiologischen Faktoren und Disseminierten Tumorzellen im Knochenmark (DTZ-KM)

Geburtshilfe und Frauenheilkunde, 2006-09, Vol.66 (S 01)

2006

Volltextzugriff (PDF)

Inzidenz zirkulierender Tumorzellen im peripheren Blut (CTC) bei Mammakarzinompatientinnen zum Zeitpunkt der Primärdiagnose – Ein potentieller Marker zur Risikostratifizierung

Geburtshilfe und Frauenheilkunde, 2006-09, Vol.66 (S 01)

2006

Volltextzugriff (PDF)

Benefit from participation in clinical trials

Geburtshilfe und Frauenheilkunde, 2006

2006

Volltextzugriff (PDF)

Luminescence properties of thin film Ta2Zn3O8 and Mn doped Ta2Zn3O8

Journal of applied physics, 1998-10, Vol.84 (8), p.4466-4470

1998

Volltextzugriff (PDF)

Bound exciton luminescence in Te-doped SrS

Journal of applied physics, 1998-10, Vol.84 (7), p.3676-3683

1998

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Abstract GS5-03: Lifestyle Intervention and Effect on Disease-free Survival in Early Breast Cancer Pts: Interim Analysis from the Randomized SUCCESS C Study

Persistenz zirkulierender Tumorzellen direkt nach und zwei Jahre nach adjuvanter Chemotherapie bei Patientinnen mit früher Brustkrebserkrankung – Ergebnisse der SUCCESS Studien

Abstract OT1-1-11: DETECT III - A multicenter, randomized, phase III trial to compare standard therapy alone versus standard therapy plus lapatinib in patients with initially HER2-negative metastatic breast cancer and HER2-positive circulating tumor cells

Abstract OT2-6-10: DETECT IV – A multicenter, single arm, phase II study evaluating the efficacy of everolimus in combination with endocrine therapy in patients with HER2-negative, hormone-receptor positive metastatic breast cancer and HER2-negative circulating tumor cells (CTCs)

Abstract P4-13-11: Prognostic factors in young breast cancer patients over time – a 40 year longitudinal analysis

Abstract PD6-6: A pooled analysis of the prognostic relevance of circulating tumor cells in early breast cancer

Abstract OT1-1-10: DETECT III - A multicenter, randomized, phase III study to compare standard therapy alone versus standard therapy plus lapatinib in patients with initially HER2-negative metastatic breast cancer but with HER2-positive circulating tumorcells

Abstract P1-10-11: Outcome of Patients with Early Breast Cancer Is Not Related to Their State of Social or Health Insurance

Abstract P3-12-09: The prevalence and quantity of circulating tumor cells (CTCs) after adjuvant chemotherapy with and without anthracyclines in patients with HER2-negative early breast cancer (EBC)

P5-14-05: Anti-Müllerian Hormone (AMH) Levels in Premenopausal Breast Cancer Patients Treated with Adjuvant Chemotherapy – A Translational Research Project of the SUCCESS Study

Abstract PD04-08: Circulating tumor cells (CTC) in peripheral blood of breast cancer patients two years after adjuvant chemotherapy depending on endocrine treatment — The German SUCCESS-Trial

Abstract P2-01-02: Circulating Tumor Cells (CTC) may Express HER2/neu in Patients With Early HER2/neu Negative Breast Cancer – Results of the German SUCCESS C Trial

Abstract P3-10-20: The Prognostic Relevance of Serum CA27.29 level in Primary Breast Cancer Patients before Adjuvant Chemotherapy — Results of the German SUCCESS Trial

CA 27.29 as a tumour marker for risk evaluation and therapy monitoring in patients with primary breast cancer

Treatment with trastuzumab in recurrence free patients with early breast cancer and persistent disseminated tumor cells (DTC) in bone marrow

Toxicity analysis of a phase III study evaluating FEC-Doc vs. FEC-Doc in combination with gemcitabine as adjuvant treatment for breast cancer – the SUCCESS-trial

Nachweis von Vascular Endothelial Growth Factor Receptor (VEGF-R) beim Mammakarzinom – Korrelation mit tumorbiologischen Faktoren und Disseminierten Tumorzellen im Knochenmark (DTZ-KM)

Benefit from participation in clinical trials

Die SUCCESS-Studie–ein innovatives Konzept zur Optimierung der adjuvanten Therapie beim frühen Mammakarzinom

Inzidenz zirkulierender Tumorzellen im peripheren Blut (CTC) bei Mammakarzinompatientinnen zum Zeitpunkt der Primärdiagnose – Ein potentieller Marker zur Risikostratifizierung

Nachweis von Vascular Endothelial Growth Factor Receptor (VEGF-R) beim Mammakarzinom – Korrelation mit tumorbiologischen Faktoren und Disseminierten Tumorzellen im Knochenmark (DTZ-KM)

Inzidenz zirkulierender Tumorzellen im peripheren Blut (CTC) bei Mammakarzinompatientinnen zum Zeitpunkt der Primärdiagnose – Ein potentieller Marker zur Risikostratifizierung

Benefit from participation in clinical trials

Luminescence properties of thin film Ta2Zn3O8 and Mn doped Ta2Zn3O8

Bound exciton luminescence in Te-doped SrS

Suchergebnisse filtern